earnings

Alkermes Breaks $1 Billion
Alkermes Breaks $1 Billion
Motley Fool
Alkermes
earnings
Flag link:
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
Yahoo/Zacks.com
Teva Pharmaceutical
earnings
Flag link:
AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales
AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales
Yahoo/Zacks.com
earnings
AstraZeneca
Flag link:
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Yahoo/Zacks.com
Teva Pharmaceutical
earnings
Flag link:
Here's Why AbbVie's Stock Tanked in January
Here's Why AbbVie's Stock Tanked in January
Motley Fool
AbbVie
earnings
Flag link:
Exelixis (EXEL) to Report Q4 Earnings: What's in Store?
Exelixis (EXEL) to Report Q4 Earnings: What's in Store?
Yahoo/Zacks.com
Exelixis
earnings
Flag link:
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Yahoo/Zacks.com
Sanofi
earnings
Flag link:
Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19
Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19
Yahoo/Zacks.com
GSK
earnings
Flag link:
Successful launch bolsters Libtayo's place as cornerstone therapy for Regeneron
Successful launch bolsters Libtayo's place as cornerstone therapy for Regeneron
Biopharma Dive
Regeneron
Libtayo
earnings
CSCC
drug launches
Flag link:
Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal
Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal
TheStreet.com
Eli Lilly
earnings
M&A
Loxo Oncology
Flag link:
Sales of shingles vaccine boost profits at GSK
Sales of shingles vaccine boost profits at GSK
Yahoo/Reuters
GSK
earnings
vaccines
shingles
Shingrix
Flag link:
Gilead Misses Mark on Earnings as Daniel O'Day Prepares to Take Helm
Gilead Misses Mark on Earnings as Daniel O'Day Prepares to Take Helm
Bloomberg
Gilead Sciences
earnings
Flag link:
Pfizer's Next 3 Years: What Investors Can Expect
Pfizer's Next 3 Years: What Investors Can Expect
Motley Fool
Pfizer
earnings
Flag link:
4 Things You Need to Know About Merck's Q4 Earnings Results
4 Things You Need to Know About Merck's Q4 Earnings Results
Motley Fool
Merck
earnings
Flag link:
Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance
Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance
Yahoo/Zacks.com
Roche
earnings
Flag link:
Celgene Takes A Step Closer To Its Bristol Merger With Solid Quarter
Celgene Takes A Step Closer To Its Bristol Merger With Solid Quarter
Investors Business Daily
Celgene
earnings
Flag link:
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
earnings
Pfizer
Amgen
AbbVie
JNJ
Merck
Novo Nordisk
Takeda
Flag link:
Merck 4Q net powered by cancer treatment sales, lower taxes
Merck 4Q net powered by cancer treatment sales, lower taxes
Yahoo/AP
Merck
earnings
Flag link:
Novo bets on swift FDA review for oral diabetes drug semaglutide
Novo bets on swift FDA review for oral diabetes drug semaglutide
Endpoints
Novo Nordisk
earnings
semaglutide
FDA
Flag link:
Edwards Lifesciences posts posts Street-beating Q4, mixed-bag 2018 earnings
Edwards Lifesciences posts posts Street-beating Q4, mixed-bag 2018 earnings
Mass Device
Edwards Lifesciences
devices
earnings
Flag link:

Pages